Literature DB >> 24781376

The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review.

Leon Peto1, Behzad Nadjm2, Peter Horby1, Ta Thi Dieu Ngan3, Rogier van Doorn1, Nguyen Van Kinh3, Heiman F L Wertheim1.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) is a major cause of adult mortality in Asia. Appropriate empirical treatment depends on knowledge of the pathogens commonly responsible. However, assessing the aetiological significance of identified organisms is often difficult, particularly with sputum isolates that might represent contamination with oropharyngeal flora.
METHODS: A systematic review of all adult CAP aetiology studies from Asia, excluding the Middle East, published in English between 1 January 1990 and 1 March 2012 was conducted. Forty-eight studies reporting on 10 423 patients were included, representing data from China, India, Indonesia, Japan, Malaysia, The Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam. Data from large parts of Asia were unavailable and there was substantial heterogeneity in methodology.
RESULTS: As in western studies, Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella spp. and Haemophilus influenzae were all significant pathogens. However, compared with western studies, S. pneumoniae was of less relative importance. Gram-negative bacilli and Mycobacterium tuberculosis were more important, and in northeast Thailand Burkholderia pseudomallei was a major pathogen.
CONCLUSION: These data have major implications for diagnostic strategies and empirical treatment. Narrow-spectrum antibiotics targeting S. pneumoniae may be inappropriate in many Asian settings, and agents active against TB may lead to partial response and delayed TB diagnosis.
© The Author 2014. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Entities:  

Keywords:  Asia; Community-acquired; Microbiology; Mycobacterium tuberculosis; Pneumonia; Streptococcus pneumoniae

Mesh:

Year:  2014        PMID: 24781376      PMCID: PMC4023908          DOI: 10.1093/trstmh/tru058

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  85 in total

1.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

2.  Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand.

Authors:  S J Olsen; S Thamthitiwat; S Chantra; M Chittaganpitch; A M Fry; J M Simmerman; H C Baggett; T C T Peret; D Erdman; R Benson; D Talkington; L Thacker; M L Tondella; J Winchell; B Fields; W L Nicholson; S Maloney; L F Peruski; K Ungchusak; P Sawanpanyalert; S F Dowell
Journal:  Epidemiol Infect       Date:  2010-03-31       Impact factor: 2.451

Review 3.  Diagnostic tests for agents of community-acquired pneumonia.

Authors:  John G Bartlett
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

4.  Significance of enteric gram-negative bacilli in the throat.

Authors:  C R Philpot; P J McDonald; K H Chai
Journal:  J Hyg (Lond)       Date:  1980-10

5.  A study on community acquired pneumonia in adults requiring hospital admission in Penang.

Authors:  L N Hooi; I Looi; A J Ng
Journal:  Med J Malaysia       Date:  2001-09

6.  An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.

Authors:  Yun-Fong Ngeow; Subharee Suwanjutha; Teerachai Chantarojanasriri; Fu Wang; Mediadora Saniel; Marissa Alejandria; Po-Ren Hsueh; Lee Ping-Ing; Seung-Chul Park; Jang-Wook Sohn; Ahmad M Aziah; Youning Liu; Wing-Hong Seto; Cecilia C L Ngan; Mangunnegoro Hadiarto; Alsagaff Hood; Yuet-Meng Cheong
Journal:  Int J Infect Dis       Date:  2004-11-25       Impact factor: 3.623

7.  Severe community-acquired pneumonia in Singapore.

Authors:  K H Lee; K P Hui; W C Tan; T K Lim
Journal:  Singapore Med J       Date:  1996-08       Impact factor: 1.858

8.  Bacteriological and clinical profile of Community acquired pneumonia in hospitalized patients.

Authors:  Bashir Ahmed Shah; Gurmeet Singh; Muzafar Ahmed Naik; Ghulam Nabi Dhobi
Journal:  Lung India       Date:  2010-04

9.  TB presenting as community-acquired pneumonia in a setting of high TB incidence and high HIV prevalence.

Authors:  K Nyamande; U G Lalloo; M John
Journal:  Int J Tuberc Lung Dis       Date:  2007-12       Impact factor: 2.373

10.  Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah).

Authors:  A Alzeer; A Mashlah; N Fakim; N Al-Sugair; M Al-Hedaithy; S Al-Majed; G Jamjoom
Journal:  J Infect       Date:  1998-05       Impact factor: 6.072

View more
  51 in total

Review 1.  The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001-2015: A systematic review.

Authors:  Guijun Ning; Xuxia Wang; Dan Wu; Zundong Yin; Yixing Li; Huaqing Wang; Weizhong Yang
Journal:  Hum Vaccin Immunother       Date:  2017-09-18       Impact factor: 3.452

2.  Impact of on-site Xpert on TB diagnosis and mortality trends in Uganda.

Authors:  S Walusimbi; I Najjingo; S Zawedde-Muyanja; J Musaazi; A Nyombi; W Katagira; J Ssendiwala; W Muttamba
Journal:  Public Health Action       Date:  2022-06-21

3.  Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital.

Authors:  Jaturon Poovieng; Boonsub Sakboonyarat; Worapong Nasomsong
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

4.  Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis.

Authors:  Ya-Lin Jiang; Hong-Yan Liu; Min-Min Tang; Jia-Yi Cheng; Hui Zhao; Lin Fu
Journal:  Front Med (Lausanne)       Date:  2022-06-17

Review 5.  Nemonoxacin: first global approval.

Authors:  Raewyn M Poole
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

6.  Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012.

Authors:  Carmen Lucía Contreras; Jennifer R Verani; María Renee Lopez; Antonio Paredes; Chris Bernart; Fabiola Moscoso; Aleida Roldan; Wences Arvelo; Kim A Lindblade; John P McCracken
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

7.  Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report.

Authors:  Shoji Suzuki; Naoki Nishimura; Torahiko Jinta; Yasuhiko Yamano; Genta Ishikawa; Yutaka Tomishima; Noboru Uchiyama; Naohiko Chohnabayashi
Journal:  Multidiscip Respir Med       Date:  2016-06-20

8.  Epidemiology, microbiology and treatment implications in adult patients hospitalized with pneumonia in different regions of China: a retrospective study.

Authors:  Fan Liu; Zehuai Wen; Jia Wei; Huiling Xue; Yunqin Chen; Weiguo Gao; David Melnick; Jesus Gonzalez; Judith Hackett; Xiaoyan Li; Shizhou Deng; Zhaolong Cao
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

9.  Evaluation of the Bruker Biotyper Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry System for Identification of Clinical and Environmental Isolates of Burkholderia pseudomallei.

Authors:  He Wang; Ya-Lei Chen; Shih-Hua Teng; Zhi-Peng Xu; Ying-Chun Xu; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2016-04-08       Impact factor: 5.640

10.  Retrospective cohort evaluation on risk of pneumonia in patients with pulmonary tuberculosis.

Authors:  Tsui-Ming Chang; Chih-Hsin Mou; Te-Chun Shen; Chien-Lung Yang; Min-Hui Yang; Fang-Yang Wu; Fung-Chang Sung
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.